Patents by Inventor Thomas B. Ryder

Thomas B. Ryder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080032408
    Abstract: The invention provides a unique set of nucleic acid sequences which is appropriate for use for a wide variety of applications requiring nucleic acid tags. As such, the sequence tags of the presently claimed invention may be used, for example, to label biological and nonbiological materials, in genotyping applications and in a variety of other analyses.
    Type: Application
    Filed: November 22, 2006
    Publication date: February 7, 2008
    Applicant: Affymetrix, INC.
    Inventors: Michael Mittmann, MacDonald Morris, Thomas B. Ryder, David Lockhart
  • Patent number: 7157564
    Abstract: The invention provides a unique set of nucleic acid sequences which is appropriate for use for a wide variety of applications requiring nucleic acid tags. As such, the sequence tags of the presently claimed invention may be used, for example, to label biological and nonbiological materials, in genotyping applications and in a variety of other analyses.
    Type: Grant
    Filed: April 4, 2001
    Date of Patent: January 2, 2007
    Assignee: Affymetrix, Inc.
    Inventors: Michael Mittmann, MacDonald Morris, Thomas B. Ryder, David Lockhart
  • Patent number: 7009041
    Abstract: A method, composition and kit for synthesizing multiple copies of a target nucleic acid sequence autocatalytically under conditions of substantially constant temperature, ionic strength, and pH are provided in which multiple RNA copies of the target sequence autocatalytically generate additional copies using a mixture of blocked and unblocked primers and/or promoter-primers to initiate DNA and RNA synthesis, preferably with reduced non-specific product formation. The invention is useful for generating copies of a nucleic acid target sequence for purposes that include assays to quantitate specific nucleic acid sequences in clinical, environmental, forensic and similar samples, cloning and generating probes.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 7, 2006
    Assignee: Gen-Probe Incorporated
    Inventors: Sherrol H. McDonough, Daniel L. Kacian, Nanibhushan Dattagupta, Diane L. McAllister, Philip W. Hammond, Thomas B. Ryder
  • Patent number: 6806047
    Abstract: Methods and compounds are provided for detecting target molecules in a sample using specific binding assays. In particular, methods are provided for detecting a nucleic acid target in a sample. In one embodiment, the method comprises hybridizing a nucleic acid target, comprising a target nucleic acid sequence, to a nucleic acid probe, comprising a probe nucleic acid sequence, wherein the target comprises a binding ligand. The hydridized target is contacted with a receptor comprising multiple sites capable of binding the binding ligand to complex the receptor to the binding ligand, and the receptor is contacted with an amplification reagent, comprising a plurality of the binding ligands, to complex the amplification reagent to the receptor. The presence of the complexed amplification reagent then is detected, for example, by detecting the presence of a detectable label, such as a fluorescent label, for example, on the receptor or the amplification reagent.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: October 19, 2004
    Assignee: Affymetrix, Inc.
    Inventors: Martin J. Goldberg, Govinda Rao S. Yelagalawadi, Eugene Yuji Tanimoto, Huu Minh Tran, Helin Dong, David Lockhart, Thomas B. Ryder, Janet A. Warrington, Jody Beecher
  • Publication number: 20040185490
    Abstract: A method for determining the genotype of one or more individuals at a polymorphic locus employs amplification of a region of DNA using primers containing tags and hybridization of the products to one or more probes on a solid support. The genotype or ratio of alleles is identified from the pattern of hybridization. The method can also be used to determine the frequency of different alleles in a population.
    Type: Application
    Filed: March 22, 2004
    Publication date: September 23, 2004
    Applicant: Affymetrix, Inc.
    Inventors: Xiaohua Huang, Thomas B. Ryder, Paul Kaplan
  • Publication number: 20040137493
    Abstract: Methods and compounds are provided for detecting target molecules in a sample using specific binding assays. In particular, methods are provided for detecting a nucleic acid target in a sample. In one embodiment, the method comprises hybridizing a nucleic acid target, comprising a target nucleic acid sequence, to a nucleic acid probe, comprising a probe nucleic acid sequence, wherein the target comprises a binding ligand. The hydridized target is contacted with a receptor comprising multiple sites capable of binding the binding ligand to complex the receptor to the binding ligand, and the receptor is contacted with an amplification reagent, comprising a plurality of the binding ligands, to complex the amplification reagent to the receptor. The presence of the complexed amplification reagent then is detected, for example, by detecting the presence of a detectable label, such as a fluorescent label, for example, on the receptor or the amplification reagent.
    Type: Application
    Filed: January 7, 2004
    Publication date: July 15, 2004
    Applicant: Affymetrix, Inc.
    Inventors: Martin J. Goldberg, Govinda Rao S. Yelagalawadi, Eugene Yuji Tanimoto, Huu Minh Tran, Helin Dong, David Lockhart, Thomas B. Ryder, Janet A. Warrington, Jody Beecher
  • Patent number: 6709816
    Abstract: A method for determining the genotype of one or more individuals at a polymorphic locus employs amplification of a region of DNA using primers containing tags and hybridization of the products to one or more probes on a solid support. The genotype or ratio of alleles is identified from the pattern of hybridization. The method can also be used to determine the frequency of different alleles in a population.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: March 23, 2004
    Assignee: Affymetrix, Inc.
    Inventors: Xiaohua Huang, Thomas B Ryder, Paul Kaplan
  • Patent number: 6649749
    Abstract: Amplification oligonucleotides and hybridization assay probes which distinguish Human Immunodeficiency Virus type 1 from other viruses.
    Type: Grant
    Filed: January 20, 2001
    Date of Patent: November 18, 2003
    Assignee: Gen-Probe Incorporated
    Inventors: Sherrol H. McDonough, Thomas B. Ryder, Yeasing Yang
  • Patent number: 6582938
    Abstract: The present invention relates to the amplification of nucleic acids, preferably from mRNA. A primer and promoter are added to a target sequence to be amplified and then the target is amplified in an in vitro transcription reaction.
    Type: Grant
    Filed: May 11, 2001
    Date of Patent: June 24, 2003
    Assignee: Affymetrix, Inc.
    Inventors: Xing Su, Helin Dong, Thomas B. Ryder
  • Publication number: 20020111746
    Abstract: Methods and computer software products are provided for analyzing gene expression data. In one embodiment, non-parametric statistics is used to determine whether a transcript is detected in a sample.
    Type: Application
    Filed: December 12, 2000
    Publication date: August 15, 2002
    Inventors: Wei-min Liu, Rui Mei, Thomas B. Ryder
  • Publication number: 20020062016
    Abstract: Amplification oligonucleotides and hybridization assay probes which distinguish Human Immunodeficiency Virus type 1 from other viruses.
    Type: Application
    Filed: January 20, 2001
    Publication date: May 23, 2002
    Applicant: Gen-Probe Incorporated
    Inventors: Sherrol H. McDonough, Thomas B. Ryder, Yeasing Yang
  • Publication number: 20010049108
    Abstract: The present invention provides a variety of methods for reducing non-specific binding of a target molecule or plurality of target molecules to an array of oligonucleotides. The methods of the present invention include surface modification techniques and oligonucleotide modification techniques. According to one method of the present invention, non-specific binding of a target molecule to an array of oligonucleotides is reduced by replacing at least one of: i) the protecting groups on each of the plurality of oligonucleotides, and ii) the protecting groups on each of the protected regions of the substrate, with a negatively charged phosphate residue.
    Type: Application
    Filed: May 23, 2001
    Publication date: December 6, 2001
    Inventors: Glenn McGall, Martin Goldberg, Thomas B. Ryder, Steve Woodman
  • Publication number: 20010041335
    Abstract: Methods and compounds are provided for detecting target molecules in a sample using specific binding assays. In particular, methods are provided for detecting a nucleic acid target in a sample. In one embodiment, the method comprises hybridizing a nucleic acid target, comprising a target nucleic acid sequence, to a nucleic acid probe, comprising a probe nucleic acid sequence, wherein the target comprises a binding ligand. The hydridized target is contacted with a receptor comprising multiple sites capable of binding the binding ligand to complex the receptor to the binding ligand, and the receptor is contacted with an amplification reagent, comprising a plurality of the binding ligands, to complex the amplification reagent to the receptor. The presence of the complexed amplification reagent then is detected, for example, by detecting the presence of a detectable label, such as a fluorescent label, for example, on the receptor or the amplification reagent.
    Type: Application
    Filed: February 6, 2001
    Publication date: November 15, 2001
    Applicant: Affymetrix, Inc.
    Inventors: Martin J. Goldberg, Govinda Rao S. Yelagalawadi, Eugene Yuji Tanimoto, Huu Minh Tran, Helin Dong, David Lockhart, Thomas B. Ryder, Janet A. Warrington, Jody Beecher
  • Patent number: 6252059
    Abstract: Amplification oligonucleotides and hybridization assay probes which distinguish Human Immunodeficiency Virus type 1 from other viruses.
    Type: Grant
    Filed: January 26, 1998
    Date of Patent: June 26, 2001
    Assignee: Gen-Probe Incorporated
    Inventors: Sherrol H. McDonough, Thomas B. Ryder, Yeasing Yang
  • Patent number: 6203989
    Abstract: Methods and compounds are provided for detecting target molecules in a sample using specific binding assays. In particular, methods are provided for detecting a nucleic acid target in a sample. In one embodiment, the method comprises hybridizing a nucleic acid target, comprising a target nucleic acid sequence, to a nucleic acid probe, comprising a probe nucleic acid sequence, wherein the target comprises a binding ligand. The hydridized target is contacted with a receptor comprising multiple sites capable of binding the binding ligand to complex the receptor to the binding ligand, and the receptor is contacted with an amplification reagent, comprising a plurality of the binding ligands, to complex the amplification reagent to the receptor. The presence of the complexed amplification reagent then is detected, for example, by detecting the presence of a detectable label, such as a fluorescent label, for example, on the receptor or the amplification reagent.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: March 20, 2001
    Assignee: Affymetrix, Inc.
    Inventors: Martin J. Goldberg, Govinda Rao S. Yelagalawadi, Eugene Yuji Tanimoto, Huu Minh Tran, Helin Dong, David Lockhart, Thomas B. Ryder, Janet A. Warrington, Jody Beecher
  • Patent number: 5856088
    Abstract: Amplification oligonucleotides and hybridization assay probes which distinguish Human Immunodeficiency Virus type from other viruses.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 5, 1999
    Assignee: Gen-Probe Incorporated
    Inventors: Sherrol H. McDonough, Thomas B. Ryder, Yeasing Yang
  • Patent number: 5786183
    Abstract: A method for amplification of a nucleic acid strand in a test sample. The method includes contacting the nucleic acid strand from the test sample simultaneously with at least three oligonucleotide primers. At least one primer is a promoter-primer, and at least one other primer is complementary to the nucleic acid strand, and one other primer is complementary to a strand complementary to the nucleic acid strand. The method further includes contacting the nucleic acid strand and primers with one or more proteins having RNA-directed and/or DNA-directed DNA polymerase activities, an RNA polymerase activity, and an RNAse H activity under primer-extension conditions to allow amplification of a target region in the nucleic acid strand at essentially constant temperature.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: July 28, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Thomas B. Ryder, Elizabeth R. Billyard, Nanibhushan Dattagupta
  • Patent number: 5766849
    Abstract: A method, composition and kit for synthesizing multiple copies of a target nucleic acid sequence autocatalytically under conditions of substantially constant temperature, ionic strength, and pH are provided in which multiple RNA copies of the target sequence autocatalytically generate additional copies using a mixture of blocked and unblocked primers and/or promoter-primers to initiate DNA and RNA synthesis, preferably with reduced non-specific product formation. The invention is useful for generating copies of a nucleic acid target sequence for purposes that include assays to quantitate specific nucleic acid sequences in clinical, environmental, forensic and similar samples, cloning and generating probes.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: June 16, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Sherrol H. McDonough, Daniel L. Kacian, Nanibhushan Dattagupta, Diane L. McAllister, Philip W. Hammond, Thomas B. Ryder
  • Patent number: 5733781
    Abstract: The present invention concerns the use of oligonucleotides to inhibit propagation of human immunodeficiency virus (HIV). Preferred HIV target sites are identified and oligonucleotides designed to hybridize to a target site, or be analogous to a target site, are described. The preferred use of the oligonucleotides is to inhibit HIV propagation in a patient infected with HIV.
    Type: Grant
    Filed: July 19, 1994
    Date of Patent: March 31, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Thomas B. Ryder, Theodore Jesse Kwoh
  • Patent number: 5712385
    Abstract: Amplification oligonucleotides and hybridization assay probes which distinguish Human Immunodeficiency Virus type 1 from other viruses.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 27, 1998
    Assignee: Gen-Probe Incorporated
    Inventors: Sherrol H. McDonough, Thomas B. Ryder, Yeasing Yang